CirculoGene Theranostics is a biotechnology company that specializes in developing and commercializing liquid biopsy tests for cancer diagnosis and treatment. The company's proprietary technology platform, CirculoChip, enables the detection of cancer biomarkers in blood samples with high sensitivity and specificity. CirculoGene's liquid biopsy tests can be used for early cancer detection, monitoring of treatment response, and detection of cancer recurrence. The company is headquartered in Atlanta, Georgia and was founded in 2015.